Phio Pharmaceuticals Granted U.S. Patent #11,279,934 Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

Someone with a lot of money to spend has taken a bearish stance on Lowe's Companies (NYSE:LOW). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.